Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects

Clostridium difficile infection (CDI) has significant clinical impact especially on the elderly and/or immunocompromised patients. The pathogenicity of Clostridium difficile is mainly mediated by two exotoxins: toxin A (TcdA) and toxin B (TcdB). These toxins primarily disrupt the cytoskeletal struct...

Full description

Bibliographic Details
Main Authors: Stefano Di Bella, Paolo Ascenzi, Steven Siarakas, Nicola Petrosillo, Alessandra di Masi
Format: Article
Language:English
Published: MDPI AG 2016-05-01
Series:Toxins
Subjects:
Online Access:http://www.mdpi.com/2072-6651/8/5/134
_version_ 1811300614937772032
author Stefano Di Bella
Paolo Ascenzi
Steven Siarakas
Nicola Petrosillo
Alessandra di Masi
author_facet Stefano Di Bella
Paolo Ascenzi
Steven Siarakas
Nicola Petrosillo
Alessandra di Masi
author_sort Stefano Di Bella
collection DOAJ
description Clostridium difficile infection (CDI) has significant clinical impact especially on the elderly and/or immunocompromised patients. The pathogenicity of Clostridium difficile is mainly mediated by two exotoxins: toxin A (TcdA) and toxin B (TcdB). These toxins primarily disrupt the cytoskeletal structure and the tight junctions of target cells causing cell rounding and ultimately cell death. Detectable C. difficile toxemia is strongly associated with fulminant disease. However, besides the well-known intestinal damage, recent animal and in vitro studies have suggested a more far-reaching role for these toxins activity including cardiac, renal, and neurologic impairment. The creation of C. difficile strains with mutations in the genes encoding toxin A and B indicate that toxin B plays a major role in overall CDI pathogenesis. Novel insights, such as the role of a regulator protein (TcdE) on toxin production and binding interactions between albumin and C. difficile toxins, have recently been discovered and will be described. Our review focuses on the toxin-mediated pathogenic processes of CDI with an emphasis on recent studies.
first_indexed 2024-04-13T06:53:57Z
format Article
id doaj.art-59102c6721bd4da8acf3054c28bb8ad7
institution Directory Open Access Journal
issn 2072-6651
language English
last_indexed 2024-04-13T06:53:57Z
publishDate 2016-05-01
publisher MDPI AG
record_format Article
series Toxins
spelling doaj.art-59102c6721bd4da8acf3054c28bb8ad72022-12-22T02:57:18ZengMDPI AGToxins2072-66512016-05-018513410.3390/toxins8050134toxins8050134Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal EffectsStefano Di Bella0Paolo Ascenzi1Steven Siarakas2Nicola Petrosillo3Alessandra di Masi42nd Infectious Diseases Division, National Institute for Infectious Diseases “L. Spallanzani”, Rome 00149, ItalyDepartment of Science, Roma Tre University, Rome 00154, ItalyDepartment of Microbiology and Infectious Diseases, Concord Repatriation General Hospital, Sydney 2139, Australia2nd Infectious Diseases Division, National Institute for Infectious Diseases “L. Spallanzani”, Rome 00149, ItalyDepartment of Science, Roma Tre University, Rome 00154, ItalyClostridium difficile infection (CDI) has significant clinical impact especially on the elderly and/or immunocompromised patients. The pathogenicity of Clostridium difficile is mainly mediated by two exotoxins: toxin A (TcdA) and toxin B (TcdB). These toxins primarily disrupt the cytoskeletal structure and the tight junctions of target cells causing cell rounding and ultimately cell death. Detectable C. difficile toxemia is strongly associated with fulminant disease. However, besides the well-known intestinal damage, recent animal and in vitro studies have suggested a more far-reaching role for these toxins activity including cardiac, renal, and neurologic impairment. The creation of C. difficile strains with mutations in the genes encoding toxin A and B indicate that toxin B plays a major role in overall CDI pathogenesis. Novel insights, such as the role of a regulator protein (TcdE) on toxin production and binding interactions between albumin and C. difficile toxins, have recently been discovered and will be described. Our review focuses on the toxin-mediated pathogenic processes of CDI with an emphasis on recent studies.http://www.mdpi.com/2072-6651/8/5/134Clostridium difficiletoxinspathogenesis
spellingShingle Stefano Di Bella
Paolo Ascenzi
Steven Siarakas
Nicola Petrosillo
Alessandra di Masi
Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects
Toxins
Clostridium difficile
toxins
pathogenesis
title Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects
title_full Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects
title_fullStr Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects
title_full_unstemmed Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects
title_short Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects
title_sort clostridium difficile toxins a and b insights into pathogenic properties and extraintestinal effects
topic Clostridium difficile
toxins
pathogenesis
url http://www.mdpi.com/2072-6651/8/5/134
work_keys_str_mv AT stefanodibella clostridiumdifficiletoxinsaandbinsightsintopathogenicpropertiesandextraintestinaleffects
AT paoloascenzi clostridiumdifficiletoxinsaandbinsightsintopathogenicpropertiesandextraintestinaleffects
AT stevensiarakas clostridiumdifficiletoxinsaandbinsightsintopathogenicpropertiesandextraintestinaleffects
AT nicolapetrosillo clostridiumdifficiletoxinsaandbinsightsintopathogenicpropertiesandextraintestinaleffects
AT alessandradimasi clostridiumdifficiletoxinsaandbinsightsintopathogenicpropertiesandextraintestinaleffects